Literature DB >> 19439755

Bevacizumab in hereditary hemorrhagic telangiectasia.

Prithviraj Bose, Jennifer L Holter, George B Selby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19439755     DOI: 10.1056/NEJMc0901421

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  36 in total

Review 1.  Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.

Authors:  Shom Goel; Andus Hon-Kit Wong; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

2.  Bevacizumab treatment in hereditary hemorrhagic teleangiectasia.

Authors:  Sebastian Föllner; Michael Ibe; Jens Schreiber
Journal:  Eur J Clin Pharmacol       Date:  2012-05-30       Impact factor: 2.953

Review 3.  Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.

Authors:  Jialing Liu; Yongting Wang; Yosuke Akamatsu; Chih Cheng Lee; R Anne Stetler; Michael T Lawton; Guo-Yuan Yang
Journal:  Prog Neurobiol       Date:  2013-11-27       Impact factor: 11.685

4.  Hereditary haemorrhagic telangiectasia: From symptomatic management to pathogenesis based treatment.

Authors:  Francisco José Fernández-Fernández
Journal:  Eur J Hum Genet       Date:  2009-11-04       Impact factor: 4.246

5.  Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model.

Authors:  Samantha Lin Chiou Lee; Pegah Rouhi; Lasse Dahl Jensen; Danfang Zhang; Hong Ji; Giselbert Hauptmann; Philip Ingham; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-03       Impact factor: 11.205

6.  [Rendu-Osler-Weber disease : More than just a nosebleed].

Authors:  E Lücke; J Schreiber; M Zencker; R Braun-Dullaeus; J Herold
Journal:  Internist (Berl)       Date:  2016-06       Impact factor: 0.743

7.  Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia.

Authors:  Franck Lebrin; Samly Srun; Karine Raymond; Sabrina Martin; Stieneke van den Brink; Catarina Freitas; Christiane Bréant; Thomas Mathivet; Bruno Larrivée; Jean-Léon Thomas; Helen M Arthur; Cornelis J J Westermann; Frans Disch; Johannes J Mager; Repke J Snijder; Anne Eichmann; Christine L Mummery
Journal:  Nat Med       Date:  2010-04-04       Impact factor: 53.440

8.  First Case of Radiation-Induced Diffuse Hemorrhagic Gastritis Successfully Treated with Intravenous Bevazicumab.

Authors:  Frédérique Maire; Nelly Muller; Philippe Lévy
Journal:  Am J Gastroenterol       Date:  2017-08       Impact factor: 10.864

Review 9.  Cerebrovascular disorders: molecular insights and therapeutic opportunities.

Authors:  Erik Storkebaum; Annelies Quaegebeur; Miikka Vikkula; Peter Carmeliet
Journal:  Nat Neurosci       Date:  2011-10-26       Impact factor: 24.884

10.  A retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia.

Authors:  C Rohrmeier; H G Sachs; T S Kuehnel
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-31       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.